Note 12 - Equity Incentive Schemes (Tables)

12 Months Ended

Dec. 31, 2024

	Number of options			Weighted average exercise price A$
Balance at December 31, 2023		11,650,300			0.49
Exercised		(2,364,666	)		0.20
Lapsed		(216,300	)		0.50
Balance at December 31, 2024		9,069,334			0.57

Exercise price A$	Options		Weighted average remaining life in years		Options exercisable shares
0.25		2,364,667		0.25		2,364,667
0.30		2,364,667		0.25		2,364,667
0.30		500,000		0.25		500,000
0.92		1,920,000		0.25		1,920,000
1.00		1,920,000		0.25		1,920,000
		9,069,334				9,069,334

Period ending

Number of options exercised and

corresponding number of shares issued

Weighted average

exercise price A$

Proceeds received A$

2024

2,364,666

0.20

472,933

2023

0.00

	Number of rights			Weighted average exercise price A$
Balance at December 31, 2023		7,500,000			0.00
Granted		750,000			0.00
Lapsed		(750,000	)		0.00
Balance at December 31, 2024		7,500,000			0.00

Exercise price A$

Rights

Weighted average

remaining life in years

Rights exercisable

shares

7,500,000

UNIVERSAL BIOSENSORS INC 10-K